The current CLSD market cap is 105.47M. The company's latest EPS is USD -0.5279 and P/E is -3.01.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 266k | 330k | 4k | 1.02M | 859k |
Operating Income | -6.72M | -8.07M | -7.61M | -7.27M | -7.05M |
Net Income | -7.83M | -9.66M | -9.28M | -9.11M | -9.27M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 30k | 2.17M | 7.89M | 29.58M | 1.33M |
Operating Income | -82.95M | -30.3M | -17.94M | -627k | -30.28M |
Net Income | -82.82M | -30.77M | -18.21M | 376k | -32.95M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 55.69M | 51.3M | 44.7M | 39.19M | 34.42M |
Total Liabilities | 37.14M | 40.7M | 42M | 44.16M | 47.27M |
Total Equity | 18.55M | 10.61M | 2.7M | -4.97M | -12.85M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 44.12M | 26.78M | 19.32M | 42.9M | 51.3M |
Total Liabilities | 20.5M | 15.62M | 10.56M | 4.93M | 40.7M |
Total Equity | 23.62M | 11.16M | 8.76M | 37.98M | 10.61M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -7.76M | -13.37M | -7.22M | -12.56M | -18.63M |
Investing | -155k | -246k | -115k | -1.21M | -1.66M |
Financing | 30.76M | 31.33M | 332k | 354k | 671k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -79.2M | -27.07M | -13.12M | -10.73M | -13.37M |
Investing | -3.76M | 32.93M | -55k | N/A | -246k |
Financing | 81.78M | 8.7M | 7.87M | 23.78M | 31.33M |
Market Cap | 105.47M |
Price to Earnings Ratio | -3.01 |
Price to Sales Ratio | 74.65 |
Price to Cash Ratio | 2.06 |
Price to Book Ratio | 9.36 |
Dividend Yield | - |
Shares Outstanding | 62.41M |
Average Volume (1 week) | 928.18k |
Average Volume (1 Month) | 620.07k |
52 Week Change | 64.08% |
52 Week High | 2.12 |
52 Week Low | 0.650101 |
Spread (Intraday) | 0.14 (8.19%) |
Company Name | Clearside Biomedical Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.clearsidebio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.